Is compounded semaglutide safe?

Compounded semaglutide is prepared by USP-compliant licensed pharmacies. The safety profile is based on the known pharmacology of semaglutide as established in extensive clinical trials. However compounded medications are not evaluated by the FDA for safety, efficacy, or quality. Your physician will review your health history and discuss individual risk factors before prescribing.

How is compounded semaglutide different from Ozempic or Wegovy?

Ozempic (approved 2017) and Wegovy (approved 2021) are FDA-approved branded products manufactured by Novo Nordisk. Compounded semaglutide contains the same active ingredient but is prepared by an independent 503A compounding pharmacy. It is not equivalent to the branded products and has not undergone the same FDA review process.

How much does semaglutide cost through kindr?

Pricing is determined following physician evaluation based on your prescribed dose and protocol. Contact support@kindr.health for current pricing information after submitting your evaluation request.

How is semaglutide administered?

Semaglutide is administered as a subcutaneous (under the skin) injection, typically once weekly. Your physician will provide specific administration instructions. Injection sites include the abdomen, thigh, or upper arm.

Who provides my prescription?

All prescribing is performed by licensed independent physicians employed by or contracted with Arora Health & Aesthetics, LLC, 300 Lenora Street, Seattle WA 98121. kindr Health does not make clinical determinations.

What states does kindr serve?

kindr Health and VialsRX serve all 50 US states. Physicians are licensed in your state and medications ship nationally.

What happens if I stop taking semaglutide?

Clinical data shows that weight typically returns following discontinuation of semaglutide. The SELECT trial and STEP extension studies demonstrated weight regain after stopping the medication. Your physician will discuss a comprehensive weight management approach including lifestyle modifications alongside pharmacological treatment.

Part of the pillar guide: Peptide Therapy — Complete Guide

kindr

GLP-1 Receptor Agonist · Weekly Injection

Compounded semaglutide. Physician-supervised. Available now.

Semaglutide is the most clinically studied GLP-1 medication in history. kindr Health provides compounded semaglutide through licensed physicians and a USP-compliant 503A pharmacy — available in all 50 states.

Request Physician Evaluation →

· Physician evaluation required· Licensed 503A pharmacy· All 50 US states· 24hr review

~15%

Average body weight reduction at 68 weeks in clinical trials

2.4mg

Maximum approved weekly dose for chronic weight management

FDA 2021

Year semaglutide was approved for weight management (Wegovy)

Compounded semaglutide is not FDA-approved. Physician evaluation required. Not equivalent to Ozempic or Wegovy.

How does semaglutide work in your body?

GLP-1 hormone mimicry

Semaglutide mimics GLP-1 (glucagon-like peptide-1) — a hormone naturally released after eating. By binding to GLP-1 receptors it signals fullness to the brain, reducing appetite and caloric intake significantly.

Gastric emptying

Semaglutide slows the rate at which food leaves the stomach. This extends the feeling of fullness after meals and reduces the post-meal blood sugar spike — improving glycemic control and reducing cravings throughout the day.

Insulin regulation

GLP-1 receptor activation stimulates insulin secretion only when blood sugar is elevated — a glucose-dependent mechanism that supports metabolic health without the hypoglycemia risk associated with older medications.

Central appetite control

Semaglutide crosses the blood-brain barrier and directly affects appetite control centers in the hypothalamus — reducing food cravings, especially for high-calorie foods, at the neurological level.

The STEP clinical trial program — one of the largest weight management trial series ever conducted — enrolled over 4,500 participants across multiple studies. STEP 1 demonstrated an average weight loss of 14.9% at 68 weeks in adults with obesity. STEP 5 showed sustained weight loss of 15.2% over 104 weeks of continuous treatment. These results established semaglutide as the most effective pharmacological weight management intervention available prior to the development of triple agonists.

References: Wilding et al. NEJM 2021 (STEP 1); Garvey et al. Nature Medicine 2022 (STEP 5).

How does compounded semaglutide compare to Ozempic and Wegovy?

Compounded semaglutide prepared by 503A pharmacies is not the same as FDA-approved Ozempic or Wegovy. Compounded medications have not been evaluated by the FDA for safety, efficacy, or quality.

Feature	Ozempic / Wegovy	Compounded Semaglutide
FDA approval	FDA-approved	Not FDA-approved
Active ingredient	Semaglutide	Semaglutide
Requires prescription	Yes	Yes
Manufactured by	Novo Nordisk	Licensed 503A pharmacy
Availability	Subject to shortages	Generally available
Cost	Insurance-dependent	Direct pay
Customizable dosing	Limited	Physician-determined

How much weight do you lose on semaglutide?

14.9%

Average weight loss

Mean weight reduction in STEP 1 trial at 68 weeks with 2.4mg weekly semaglutide plus lifestyle intervention.

NEJM 2021

83%

Participants lost >5% body weight

In STEP 1 the vast majority of participants achieved clinically meaningful weight loss compared to 31.5% in the placebo group.

NEJM 2021

15.2%

Weight loss at 2 years

STEP 5 demonstrated sustained weight loss over 104 weeks of continuous treatment — establishing semaglutide as a long-term weight management medication.

Nature Medicine 2022

20%

Reduction in major adverse cardiovascular events

The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events in adults with obesity — establishing cardiovascular benefits beyond weight loss alone.

NEJM 2023

Clinical data reflects FDA-approved semaglutide (Ozempic/Wegovy) in controlled trials. Compounded semaglutide has not been evaluated in clinical trials and results may differ.

Who may qualify

✓BMI of 30 or greater
✓BMI of 27+ with a weight-related condition (hypertension, type 2 diabetes, high cholesterol, sleep apnea, or cardiovascular disease)
✓No contraindications to GLP-1 therapy
✓Not pregnant or planning pregnancy
✓Willing to commit to physician monitoring

Contraindications

×Personal or family history of medullary thyroid carcinoma (MTC)
×Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
×History of pancreatitis
×Severe gastrointestinal disease
×Current pregnancy or breastfeeding
×Severe kidney or liver disease

What are the side effects of semaglutide?

Common (30%+ of patients)

Nausea (most common — typically mild and resolves within weeks)
Vomiting
Diarrhea
Constipation
Decreased appetite

Less common

Injection site reactions
Headache
Fatigue
Muscle loss (significant at higher doses — why kindr recommends GLP-1 Shield alongside semaglutide therapy)
Gallbladder disease (rare)

Muscle loss note

Muscle loss during semaglutide therapy is a documented clinical concern. Up to 30% of weight lost on GLP-1 medications can come from lean muscle tissue. kindr's GLP-1 Shield and Muscle Protect supplements are formulated specifically to address this — see GLP-1 Shield →

How kindr semaglutide works.

Complete the intake form

8-minute health questionnaire. A licensed physician reviews every submission personally.

Physician evaluation — 24 hours

A licensed physician from Arora Health & Aesthetics, LLC evaluates your health history and determines eligibility. Clear response within 24 hours.

Prescription and fulfillment

If approved, your prescription goes to VialsRX (Houston, TX) — a USP-compliant 503A compounding laboratory. Fulfilled in 24-48 hours.

Ongoing monitoring

Quarterly check-ins with your physician. Dose adjustments as needed. Free shipping on every refill.

Pharmacy disclosure

Compounded by VialsRX · 6220 Westpark Dr, Houston TX 77057 · (713) 497-5590 · vials.ai · USP-compliant · All 50 US states.

Request your physician evaluation.

Complete this form to be evaluated for compounded semaglutide. A licensed physician will review your submission within 24 hours.

Full name

Email address

Phone number

Date of birth

State of residence

Current weight

Height

Have you tried GLP-1 medications before?

If yes — what was your experience?

Current medical conditions

Type 2 diabetesHypertensionHigh cholesterolSleep apneaPCOSThyroid conditionNone of the above

Current medications

Additional information

I understand that compounded semaglutide is not FDA-approved and is not equivalent to Ozempic or Wegovy. I consent to physician evaluation and understand that a prescription is not guaranteed.I consent to the collection and processing of my health information in accordance with kindr Health's HIPAA Privacy Notice.

Compounded semaglutide is not FDA-approved. Not equivalent to Ozempic or Wegovy. Physician evaluation required. Prescription not guaranteed. Clinical services by Arora Health & Aesthetics, LLC. Compounded by VialsRX.

Frequently asked questions.

Compounded semaglutide is semaglutide prepared by a state-licensed 503A compounding pharmacy — in this case, VialsRX in Houston, TX. It contains the same active pharmaceutical ingredient as Ozempic and Wegovy but is not manufactured by Novo Nordisk and is not FDA-approved. A physician prescription is required.

Start your semaglutide evaluation today.

Physician-supervised. Licensed pharmacy. All 50 states. 24-hour review.

Request Evaluation →

Compounded semaglutide available through kindr Health is prepared by VialsRX under Section 503A of the Federal Food Drug and Cosmetic Act. It is not an FDA-approved drug and is not equivalent to Ozempic or Wegovy. Clinical services provided by Arora Health & Aesthetics, LLC. Prescription required. Not guaranteed. This page is for informational purposes and does not constitute medical advice.

Related kindr resources

GLP-1 Complete Bundle →GLP-1 Shield supplement →Retatrutide →How it works →

Keep reading

Tirzepatide

Dual GIP/GLP-1 agonist — the next generation of weight management therapy.

Read Tirzepatide →

Retatrutide

Investigational triple agonist with the highest weight loss in trials to date.

Read Retatrutide →

GLP-1 Complete program

Full physician-supervised program with labs, dosing, and clinical support.

Read GLP-1 Complete program →

Medically reviewed by Dr. Ana Lisa Carr, MD, MBA
Board-Certified Family Medicine Physician · Lead Provider / Medical Reviewer
NPI 1689841744 · Last reviewed: May 10, 2026

Latest from the Journal

Weight & metabolism
HRT vs GLP-1 for menopause weight loss: which is right for you?
Hormone therapy addresses the hormonal causes of midlife weight gain. GLP-1s like semaglutide target appetite and metabolism. Here is how they differ — and when to use one, the other, or both.
Read HRT vs GLP-1 for menopause weight loss: which is right for you? →
Lifestyle
Strength training in menopause: the single most important habit after 40
Estrogen loss accelerates muscle and bone decline. Resistance training — done correctly — is the closest thing we have to a medication for it.
Read Strength training in menopause: the single most important habit after 40 →
Perimenopause
Understanding perimenopause: the years before menopause
Perimenopause can begin in your late 30s or 40s and last up to a decade. Here is what is happening hormonally and what actually helps.
Read Understanding perimenopause: the years before menopause →